Vaginal yeast colonization in nonpregnant women: a longitudinal study

Obstetrics and Gynecology

Volumn 104, Issue 5, 2004, Pages 926-930

  Beigi, Richard H ^a   Meyn, Leslie A ^a   Moore, Donna M ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE; INJECTABLE CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CANDIDA ALBICANS; COITUS; FEMALE; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MICROBIOLOGY; RISK FACTOR; VAGINA; VAGINITIS; ANTIFUNGAL ACTIVITY; COHORT ANALYSIS; FUNGAL COLONIZATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RISK; LACTOBACILLUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RELIABILITY; SEXUAL INTERCOURSE; STREPTOCOCCUS AGALACTIAE; VAGINA FLORA;

ADOLESCENT; ADULT; CANDIDA ALBICANS; COITUS; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MEDROXYPROGESTERONE 17-ACETATE; RISK FACTORS; VAGINA; VAGINOSIS, BACTERIAL;

EID: 16244413616     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000140687.51048.73     Document Type: Article

References (14)

1. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985;152:924-35.
2. Sobel JD. Vaginitis. N Engl J Med 1997;337:1896-903.
3. Cotch MF, Hillier SL, Gibbs RS, Eschenbach DA. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1998;178:374-80.
4. Schuman P, Sobel JD, Ohmit SE, Mayer KH, Carpenter CC, Rompalo A, et al. Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. HIV Epidemiology Research Study (HERS) Group. Clin Infect Dis 1998;27:1161-7.
5. Eschenbach DA, Patton DL, Meier A, Thwin SS, Aura J, Stapleton A, et al. Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium. Contraception 2000;62:107-12.
6. Miller L, Patton DL, Meier A, Thwin SS, Hooton TM, Eschenbach DA. Depomedroxy- progesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol 2000;96:431-9.
7. Gupta K, Hillier SL, Hooton TM, Roberts PL, Stamm WE. Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. J Infect Dis 2000;181:595-601.
8. Nyirjesy P, Weitz MV, Grody MH, Lorber B. Over-the-counter and alternative medicines in the treatment of chronic vaginal symptoms. Obstet Gynecol 1997;90:50-3.
9. Lipsky MS, Waters T. The “prescription-to-otc switch” movement: its effects on antifungal vaginitis preparations. Arch Fam Med 1999;8:297-300.
10. Linhares IM, Witkin SS, Miranda SD, Fonseca AM, Pinotti JA, Ledger WJ. Differentiation between women with vulvovaginal symptoms who are positive or negative for Candida species by culture. Infect Dis Obstet Gynecol 2001;9:221-25.
11. Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS. Over-the-counter antifungal drug misuse associated patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002;99:419-25.
12. Ferris DG, Dekle C, Litaker MS. Women's use of over-the-counter antifungal medications for gynecologic symptoms. J Fam Pract 1996;42:595-600.
13. Meyn LA, Moore DM, Hillier SL, Krohn MA. Association of sexual activity with colonization and vaginal acquisition of Group B streptococcus in non-pregnant women. Am J Epidemiol 2002;155:949-57.
14. Hardin JW, Hilbe JM. Generalized estimating equations. Boca Raton (FL): Chapman & Hall/CRC; 2003.